Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Rabindra R. Watson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1429-7381; OpenAlex author ID A5058601116. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 7

  1. Circulating tumor cell and oncosome subtypes in portal and peripheral venous circulations may be used for diagnosis and prognostication of pancreatic cancer. Co-author DOI 10.1038/s41698-025-01165-4↗
  2. Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal ade… Co-author DOI 10.3389/fonc.2025.1611872↗
  3. Increasing Pancreatic Cancer Incidence in Young Women in the United States: A Population-Based Time-Trend Analysis, 2001-2018. Co-author DOI 10.1053/j.gastro.2023.01.022↗
  4. Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000-2018. Co-author DOI 10.3390/cancers15030870↗
  5. The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer after Neoadjuvant Therapy. Last author DOI 10.1007/s11605-019-04415-6↗
  6. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Co-author DOI 10.1038/bjc.2016.121↗
  7. Plastic biliary stent patency in patients with locally advanced pancreatic adenocarcinoma receiving downstaging chemotherapy. Co-author DOI 10.1016/j.gie.2014.08.020↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Simon K. Lo · 4 shared papers, 2023–2025 · strength 0.75
  2. Stephen Jacob Pandol · 4 shared papers, 2023–2025 · strength 0.75
  3. Srinivas Gaddam · 4 shared papers, 2023–2025 · strength 0.75
  4. Nicholas N. Nissen · 3 shared papers, 2023–2025 · strength 0.52
  5. Andrew Eugene Hendifar · 2 shared papers, 2023 · strength 0.29
  6. Jamil S. Samaan · 2 shared papers, 2023 · strength 0.29
  7. Yazan Abboud · 2 shared papers, 2023 · strength 0.29
  8. Arsen Osipov · 2 shared papers, 2023 · strength 0.29
  9. Debiao Li · 2 shared papers, 2023 · strength 0.29
  10. Stephanie N. Shishido · 1 shared paper, 2025 · strength 0.24
  11. Peter Kühn · 1 shared paper, 2025 · strength 0.24
  12. Ruoxiang Wang · 1 shared paper, 2025 · strength 0.23
  13. Yan Ou · 1 shared paper, 2025 · strength 0.23
  14. Mouad Edderkaoui · 1 shared paper, 2025 · strength 0.23
  15. Timothy R. Donahue · 3 shared papers, 2015–2020 · strength 0.20
  16. V. Raman Muthusamy · 3 shared papers, 2015–2020 · strength 0.20
  17. Oscar Joe Hines · 2 shared papers, 2016–2020 · strength 0.16
  18. Jun Gong · 1 shared paper, 2023 · strength 0.15
  19. Daniel Lew · 1 shared paper, 2023 · strength 0.14
  20. Brent K. Larson · 1 shared paper, 2023 · strength 0.14
  21. Dean Ehrlich · 1 shared paper, 2020 · strength 0.11
  22. Phillip S. Ge · 1 shared paper, 2015 · strength 0.05
  23. Jason B. Klapman · 1 shared paper, 2015 · strength 0.05
  24. Srinadh Komanduri · 1 shared paper, 2015 · strength 0.05
  25. Janak N. Shah · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.